Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125789991 | 12578999 | 1 | I | 201511 | 20160715 | 20160721 | 20160721 | EXP | PHEH2016US017765 | NOVARTIS | 58.00 | YR | F | Y | 74.80000 | KG | 20160721 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125789991 | 12578999 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Unknown | UNK | Y | 22527 | CAPSULE | ||||||||
| 125789991 | 12578999 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | SDZC | 0 | 10 | MG | TABLET | BID | |||||
| 125789991 | 12578999 | 3 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 0 | 10 | MG | TABLET | BID | ||||||
| 125789991 | 12578999 | 4 | C | ASMANEX | MOMETASONE FUROATE | 1 | Unknown | UNK | 0 | ||||||||||
| 125789991 | 12578999 | 5 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | UNK | 0 | ||||||||||
| 125789991 | 12578999 | 6 | C | NORTRIPTYLINE HCL | NORTRIPTYLINE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 125789991 | 12578999 | 7 | C | LOTENSIN | BENAZEPRIL HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125789991 | 12578999 | 8 | C | OXYBUTYNIN HYDROCHLORIDE | OXYBUTYNIN CHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 125789991 | 12578999 | 9 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | Unknown | UNK | 0 | ||||||||||
| 125789991 | 12578999 | 10 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125789991 | 12578999 | 1 | Product used for unknown indication |
| 125789991 | 12578999 | 2 | Gait disturbance |
| 125789991 | 12578999 | 4 | Product used for unknown indication |
| 125789991 | 12578999 | 5 | Product used for unknown indication |
| 125789991 | 12578999 | 6 | Product used for unknown indication |
| 125789991 | 12578999 | 7 | Product used for unknown indication |
| 125789991 | 12578999 | 8 | Product used for unknown indication |
| 125789991 | 12578999 | 9 | Product used for unknown indication |
| 125789991 | 12578999 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125789991 | 12578999 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125789991 | 12578999 | Central nervous system lesion | |
| 125789991 | 12578999 | Drug ineffective | |
| 125789991 | 12578999 | Lung neoplasm malignant |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125789991 | 12578999 | 1 | 201601 | 0 | ||
| 125789991 | 12578999 | 2 | 2015 | 0 | ||
| 125789991 | 12578999 | 3 | 201606 | 0 | ||
| 125789991 | 12578999 | 4 | 201602 | 0 | ||
| 125789991 | 12578999 | 9 | 2015 | 0 |